Insider buying last 90 days
No open-market insider purchases were filed for DRTS in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every DRTS insider filing, plotted on the chart in Gekko.Open DRTS in Gekko
NASDAQ: DRTS
Alpha Tau Medical (DRTS) Stock Analysis & Forecast
Oct 12 close
$14.26−0.15 (−1.0%)
Gekko Brief
AI summaryOct 12 closeAlpha Tau Medical draws attention this week mainly through investor-conference appearances rather than new corporate news: the company is scheduled to present at the Investment Generation Conference in Israel on 15 October, following its participation in the Barclays Biotech 1x1 Day in New York on 6 October. Coverage also recaps its Q2 2026 results, which showed a net loss of $45.8 million, exceeding analyst estimates, largely tied to a warrant liability revaluation, alongside a maintained Buy rating from H.C.
DRTS closed at $14.26, down 1% on the day, sitting just below its 50-day average of $14.42 and well above its 200-day average of $10.08. The stock's one-year return stands at 268.5%, with a six-month gain of 86.6%. The GekkoIndex reads 60.6, placing the stock in the Accumulation zone, up 4.8 over five days. Gekko Fair Value is set at $15.74, putting the current price 9.4% below that level.
Looking ahead, the next earnings date falls on 19 November, 38 days away, outside a typical 20-trading-day holding window; the prior report on 10 August produced an 8.6% reaction. Seasonality data shows the next 20 trading days have averaged -3.3% over five years, with gains in 3 of them. Analyst consensus from three firms includes two Buy ratings and one Hold, with a consensus target of $17.80, implying 24.8% upside. No insider, Congress, or unusual options activity appears in the recent window.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Alpha Tau Medical price vs fair value
Close $14.26200-day averageGekko Fair Value $15.74
Alpha Tau Medical quick facts
- Market cap
- $1.29B
- P/E ratio
- —
- Forward P/E
- —
- EPS, TTM
- −$1.04
- Revenue, TTM
- $0
- Profit margin
- 0%
- Dividend yield
- —
- Beta
- 1.22
- Volume
- 281,398 avg 468,592
- 1-year return
- +268.5%
- Typical daily move
- ±3.9%
- Typical 20-day move
- ±8.9%
- 50-day average
- $14.42
- 200-day average
- $10.08
- Next earnings
- Nov 19
- Shares outstanding
- 92.48M
Alpha Tau Medical swing-trade checklist
Alpha Tau Medical scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed0 headwinds
- Trendmixed
Averages disagree
Close $14.26 sits between the 50-day ($14.42) and 200-day ($10.08) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
60.6, Accumulation
Reading 60.6 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
9.4% below
Price is 9.4% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 38 days
Next report Nov 19, 2026, 38 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitymixed
−3.3% on average
From this point in the calendar, the next 20 trading days averaged −3.3% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Alpha Tau Medical stock chart and price history
Alpha Tau Medical closed at $14.26 on Oct 12, 2026, +268.5% over the past year, inside a 52-week range of $3.43 to $15.79.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −1.2%
- 3 months
- +15.6%
- 6 months
- +86.6%
- 1 year
- +268.5%
The full DRTS chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open DRTS in Gekko
Follow Alpha Tau Medical through every session
Put DRTS on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track DRTS in GekkoFree for 7 days. No credit card required.
Alpha Tau Medical GekkoIndex: the smart money zone
Alpha Tau Medical’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 60.6, in the Accumulation zone, up 4.8 points over five sessions.
60.6Accumulation
Up 4.8 points over five sessions, from the Neutral zone.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 26 | +1.2% | +1.2% | ||
| Accumulation (current zone) | 162 | +0.6% | +3.1% | ||
| Neutral | 425 | +1.9% | +7.8% | ||
| Distribution | 64 | +0.8% | +3.2% | ||
| Selling | 5 | Too few readings yet | |||
Average DRTS share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.2% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the DRTS price, zone by zone.Track DRTS in Gekko
Is Alpha Tau Medical stock overvalued? Gekko Fair Value
Alpha Tau Medical trades 9.4% below Gekko Fair Value of $15.74, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Alpha Tau Medical shares are worth, recalculated every trading day.
$15.74
Gekko Fair Value, Oct 10, 2026
9.4% Undervalued
At the end of Aug 2026 the price was 1.5% above the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open DRTS in Gekko
Alpha Tau Medical insider and Congress trading
No open-market insider purchases were filed for Alpha Tau Medical, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in DRTS were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for DRTS, plotted on the chart in Gekko.Open DRTS in Gekko
Alpha Tau Medical earnings: next date and track record
Alpha Tau Medical reports on Nov 19, 2026 (38 days away), and beat the EPS estimate in 2 of its last 8 reports.
Next earnings report
Nov 19, 2026
38 days away
- EPS estimate
- −$0.14
- Revenue estimate
- $243K
2 of 8reports beat the EPS estimate
±5.6%average move across the report
7 of 8reports followed by a gain
Share-price move across each report
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 10, 2026 | −$0.50 est −$0.14 | $100K est $145K | +8.6% |
| May 18, 2026 | −$0.26 est −$0.12 | — est $50K | +3.1% |
| Mar 9, 2026 | −$0.14 est −$0.12 | — est $63K | +6.7% |
| Nov 20, 2025 | −$0.39 est −$0.12 | — | +3.8% |
| Aug 11, 2025 | −$0.13 est −$0.11 | — | −4.1% |
| May 19, 2025 | −$0.11 est −$0.13 | — est $25K | +16.8% |
| Mar 12, 2025 | −$0.13 est −$0.12 | — | +0.8% |
| Nov 21, 2024 | −$0.10 est −$0.12 | — | +0.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Alpha Tau Medical stock forecast and analyst price targets
Analysts’ average 12-month price target for Alpha Tau Medical is $17.80, +24.8% from the last close, from 3 firms rating the stock in the last 90 days.
$17.80consensus 12-month target, +24.8% from the last close
Now $14.26Avg $17.80
Low $8High $30
Each firm’s latest rating in the last 90 days: 3 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 2 | Barclays | $30 | +110.4% |
| Sep 1 | H.C. Wainwright | $16 | +12.2% |
| Aug 11 | H.C. Wainwright | $16 | +12.2% |
| Aug 11 | Piper Sandler | $8 | −43.9% |
| Aug 11 | Barclays | $17 | +19.2% |
+3.1%average 20-day move after past Accumulation readings
−3.3%average move over the next 20 trading days in the last 5 years
±3.9%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Alpha Tau Medical seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, Alpha Tau Medical averaged −3.3% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +2.0% | 3 of 5 |
| Next 10 trading days | +2.8% | 3 of 5 |
| Next 15 trading days | +0.4% | 3 of 5 |
| Next 20 trading days | −3.3% | 3 of 5 |
| Next 30 trading days | −6.0% | 3 of 5 |
For scale, DRTS’s typical 20-trading-day move in either direction is about 8.9%.
Alpha Tau Medical market cap and key statistics
Alpha Tau Medical’s market cap is $1.29B and revenue of $0 over the last twelve months.
Valuation
- Market cap
- $1.29B
- EPS, TTM
- −$1.04
- Gekko Fair Value
- $15.74
Trading
- Volume
- 281,398
- Avg volume, 20 days
- 468,592
- 52-week high
- $15.79
- 52-week low
- $3.43
- Shares outstanding
- 92.48M
Financials
- Revenue, TTM
- $0
- Profit margin
- 0%
- Return on equity
- -141.7%
- Quarterly earnings growth, YoY
- 0.0%
Risk and income
- Beta
- 1.22
- Typical daily move
- ±3.9%
- Typical 20-day move
- ±8.9%
Alpha Tau Medical stock news this week
Coverage of Alpha Tau Medical this week reads positive: 3 positive, 0 neutral and 0 negative headlines.
- Alpha Tau Medical Ltd Cl A (DRTS-Q) Stock Price and NewsThe Globe and Mail, Oct 11
- Alpha Tau Medical stock gets an October 15 conference dateAD HOC NEWS, Oct 8
- Alpha Tau to Participate in October Investor ConferencesYahoo Finance UK, Oct 5
Alpha Tau Medical peers
Alpha Tau Medical’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Neutral | 18.2% above |
| ABTAbbott Laboratories | Neutral | 14.7% below |
| DHRDanaher | Neutral | 4.5% above |
| ISRGIntuitive Surgical | Neutral | 18.8% above |
| MDTMedtronic | Neutral | 22.9% below |
| SYKStryker | Accumulation | 12.6% below |
A peer links to its own page where one exists.
Alpha Tau Medical stock FAQ
What is Alpha Tau Medical’s market cap?
Alpha Tau Medical’s market cap is $1.29B at the Oct 12, 2026 close of $14.26, with 92.48M shares outstanding.
What is the Alpha Tau Medical stock forecast?
The consensus analyst 12-month price target for Alpha Tau Medical is $17.80, +24.8% from the last close. Of the 3 firms that rated the stock in the last 90 days, 2 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Alpha Tau Medical stock overvalued or undervalued?
On Gekko’s estimate Alpha Tau Medical is undervalued: the Oct 12, 2026 close of $14.26 is 9.4% below Gekko Fair Value of $15.74. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Alpha Tau Medical report earnings next?
Alpha Tau Medical is expected to report on Nov 19, 2026 (38 days away). Analysts expect earnings of −$0.14 per share on revenue of $243K. Alpha Tau Medical beat the earnings estimate in 2 of its last 8 reports, moving 5.6% on average across the report.
What is Alpha Tau Medical’s 52-week high and low?
Alpha Tau Medical’s 52-week high is $15.79 and its 52-week low is $3.43; it closed at $14.26 on Oct 12, 2026, +268.5% over the past year. Over the last five years the shares peaked at $20.65 on Mar 24, 2022.
Is Alpha Tau Medical stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and earnings risk), 2 as mixed (trend and seasonality). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Alpha Tau Medical the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.